Letter from New Zealand … and Season's greetings.
- Published in:
- Respirology, 2018, v. 23, n. 3, p. 339, doi. 10.1111/resp.13260
- By:
- Publication type:
- Article
Works matching IS 13237799 AND DT 2018 AND VI 23 AND IP 3
Results: 21
1
2
Management of venous thromboembolism: Time to measure our performance.
- Published in:
- Respirology, 2018, v. 23, n. 3, p. 246, doi. 10.1111/resp.13257
- By:
- Publication type:
- Article
3
Pathophysiology of severe asthma: We’ve only just started.
- Published in:
- Respirology, 2018, v. 23, n. 3, p. 262, doi. 10.1111/resp.13251
- By:
- Publication type:
- Article
4
Severe asthma: We can fix it? We can try!
- Published in:
- Respirology, 2018, v. 23, n. 3, p. 260, doi. 10.1111/resp.13249
- By:
- Publication type:
- Article
5
Moving pulmonary rehabilitation forward in COPD: Stepping towards (home‐based) action.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
6
Respiratory infections in the Asia‐Pacific region: Problems and cautious optimism.
- Published in:
- Respirology, 2018, v. 23, n. 3, p. 248, doi. 10.1111/resp.13238
- By:
- Publication type:
- Article
7
Minimal important difference of target lobar volume reduction after endobronchial valve treatment for emphysema.
- Published in:
- Respirology, 2018, v. 23, n. 3, p. 306, doi. 10.1111/resp.13178
- By:
- Publication type:
- Article
8
Novel assessment tool to detect breathing pattern disorder in patients with refractory asthma.
- Published in:
- Respirology, 2018, v. 23, n. 3, p. 284, doi. 10.1111/resp.13173
- By:
- Publication type:
- Article
9
Issue Information.
- Published in:
- 2018
- Publication type:
- Table of Contents
10
Body size‐adjusted dose analysis of pirfenidone in patients with interstitial pneumonia.
- Published in:
- Respirology, 2018, v. 23, n. 3, p. 318, doi. 10.1111/resp.13145
- By:
- Publication type:
- Article
11
Serum YKL‐40 in workers at an indium‐tin oxide production facility – Reply.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
12
Serum YKL‐40 in workers at an indium‐tin oxide production facility.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
13
Pneumonia as a cardiovascular disease.
- Published in:
- Respirology, 2018, v. 23, n. 3, p. 250, doi. 10.1111/resp.13233
- By:
- Publication type:
- Article
14
Unfavourable outcome of glucocorticoid treatment in suspected idiopathic pulmonary fibrosis.
- Published in:
- Respirology, 2018, v. 23, n. 3, p. 311, doi. 10.1111/resp.13230
- By:
- Publication type:
- Article
15
Comparison of outpatient and home‐based exercise training programmes for COPD: A systematic review and meta‐analysis.
- Published in:
- Respirology, 2018, v. 23, n. 3, p. 272, doi. 10.1111/resp.13224
- By:
- Publication type:
- Article
16
Endobronchial valve placement in emphysema: When is it lung volume reduction?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
17
Surfactant protein D multimerization and gene polymorphism in COPD and asthma.
- Published in:
- Respirology, 2018, v. 23, n. 3, p. 298, doi. 10.1111/resp.13193
- By:
- Publication type:
- Article
18
Efficacy and safety of transbronchial lung biopsy for the diagnosis of lymphangioleiomyomatosis: A report of 24 consecutive patients.
- Published in:
- Respirology, 2018, v. 23, n. 3, p. 331, doi. 10.1111/resp.13190
- By:
- Publication type:
- Article
19
Serial chest CT in cryptogenic organizing pneumonia: Evolutional changes and prognostic determinants.
- Published in:
- Respirology, 2018, v. 23, n. 3, p. 325, doi. 10.1111/resp.13188
- By:
- Publication type:
- Article
20
Treatment doses in idiopathic pulmonary fibrosis: The devil is in the detail.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
21
Short‐term respiratory effects of e‐cigarettes in healthy individuals and smokers with asthma.
- Published in:
- Respirology, 2018, v. 23, n. 3, p. 291, doi. 10.1111/resp.13180
- By:
- Publication type:
- Article